Related Experiment Video
Updated: Jul 13, 2025

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
Thromboembolic Complications Following Perioperative Tranexamic Acid Administration
Ella C Eisinger1, Liam Forsythe2, Sarah Joergensen2
1Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Empirically administered tranexamic acid (TXA) did not increase mortality or venous thromboembolism (VTE) in trauma patients. However, TXA use was associated with higher transfusion volumes, suggesting its safety but warranting further research for targeted application.
Area of Science:
- Trauma care
- Pharmacology
- Critical care medicine
Background:
- Antifibrinolytic tranexamic acid (TXA) is used in trauma to reduce death.
- Its use in patients without confirmed hyperfibrinolysis and its association with complications remain unclear.
Purpose of the Study:
- To analyze the associations of empirically administered TXA in trauma patients.
- To determine if TXA use correlates with lower transfusion volumes and increased thromboembolic complications.
Main Methods:
- Retrospective cohort study of trauma patients on massive transfusion protocol (2016-2021).
- Comparison of patients who received TXA versus those who did not.
- Primary outcome: in-hospital mortality. Secondary outcomes: venous thromboembolism (VTE), transfusion volumes, coagulation measures.
- Statistical analyses included descriptive statistics, univariate analyses, and multivariable logistic regression.
Main Results:
- TXA patients had lower presenting systolic blood pressure, higher injury severity scores, and were more likely to have undergone emergency surgery.
- After adjustment, TXA was not significantly associated with mortality or VTE.
- TXA patients received significantly larger volumes of packed red blood cells, platelets, and plasma within 4 and 24 hours.
- No differences in clot stability were observed via thromboelastography.
Conclusions:
- Empiric TXA administration in trauma patients was not associated with increased mortality or VTE.
- TXA use was linked to higher transfusion requirements, potentially due to more severe bleeding.
- The safety of TXA in this cohort supports its use, but further research is needed to optimize its application.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism III: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management

